ICU Medical, Inc. (ICUI) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $127.85. It has a SharesGrow Score of 44/100, indicating a mixed investment profile with 1 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of ICUI = $462.61 (+261.8% from the current price, the stock appears undervalued). Analyst consensus target is ICUI = $179 (+40% upside).
Valuation: ICUI trades at a trailing Price-to-Earnings (P/E) of 4121.4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 285.46.
Financials: revenue is $2.2B, -0.6%/yr average growth. Net income is $732,000, growing at -45.4%/yr. Net profit margin is 0% (thin). Gross margin is 36.8% (+6.2 pp trend).
Balance sheet: total debt is $1.4B against $2.1B equity (Debt-to-Equity (D/E) ratio 0.66, moderate). Current ratio is 2.36 (strong liquidity). Debt-to-assets is 34.4%. Total assets: $4.1B.
Analyst outlook: 9 / 11 analysts rate ICUI as buy (82%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 31/100 (Fail), Growth 15/100 (Fail), Past 25/100 (Fail), Health 50/100 (Partial), Moat 60/100 (Partial), Future 94/100 (Pass), Income 30/100 (Fail).
